Pharmacokinetics and metabolism of benzophenone 2 in the rat

Toxicology

Volumn 245, Issue 1-2, 2008, Pages 11-17

  Schlecht, Christiane ^a   Klammer, Holger ^a   Frauendorf, Holm ^a   Wuttke, Wolfgang ^a   Jarry, Hubertus ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Benzophenone 2; Endocrine disruption; HPLC; Kinetics; Metabolism; MS; Rat

Indexed keywords

BENZOPHENONE 2; BENZOPHENONE DERIVATIVE; BETA GLUCURONIDASE; GLUCURONIDE; SULFATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOTRANSFORMATION; BLOOD ANALYSIS; BLOOD SAMPLING; CONJUGATE; CONTROLLED STUDY; EXCRETION; FEMALE; FIRST PASS EFFECT; HELIX POMATIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; INTESTINE WALL; ION TRAP MASS SPECTROMETRY; LIVER METABOLISM; METABOLITE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; TOXICOKINETICS; URINE LEVEL;

ADMINISTRATION, ORAL; ANIMALS; BENZOPHENONES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS, NON-STEROIDAL; FEMALE; MASS SPECTROMETRY; METABOLIC CLEARANCE RATE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; UTERUS;

HELIX POMATIA; RATTUS;

EID: 39249083930     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2007.12.015     Document Type: Article

References (21)

1. Back D.J., Madden S., and Orme M.L. Gastrointestinal metabolism of contraceptive steroids. Am. J. Obstet. Gynecol. 163 (1990) 2138-2145
2. Coughtrie M.W., Bamforth K.J., Sharp S., Jones A.L., Borthwick E.B., Barker E.V., Roberts R.C., Hume R., and Burchell A. Sulfation of endogenous compounds and xenobiotics-interactions and function in health and disease. Chem. Biol. Interact. 92 (1994) 247-256
3. Harms P.G., and Ojeda S.R. A rapid and simple procedure for chronic cannulation of the rat jugular vein. J. Appl. Physiol. 36 (1974) 391-392
4. Hirai S., Hussain A., Haddadin M., and Smith R.B. First-pass metabolism of ethinyl estradiol in dogs and rats. J. Pharm. Sci. 70 (1981) 403-406
5. Hsieh M.H., Grantham E.C., Liu B., Macapagal R., Willingham E., and Baskin L.S. In utero exposure to benzophenone-2 causes hypospadias through an estrogen receptor dependent mechanism. J. Urol. 178 (2007) 1637-1642
6. Janjua N.R., Mogensen B., Andersson A.M., Petersen J.H., Henriksen M., Skakkebaek N.E., and Wulf H.C. Systemic absorption of the sunscreens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans. J. Invest. Dermatol. 123 (2004) 57-61
7. Kunz P.Y., Galicia H.F., and Fent K. Comparison of in vitro and in vivo estrogenic activity of UV filters in fish. Toxicol. Sci. 90 (2006) 349-361
8. Miller D., Wheals B.B., Beresford N., and Sumpter J.P. Estrogenic activity of phenolic additives determined by an in vitro yeast bioassay. Environ. Health Perspect. 109 (2001) 133-138
9. Mutschler E., Geisslinger G., Kroemer H.K., and Schäfer-Korting M. Arzneimittelwirkungen (2001), Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
10. Nishihara T., Nishikawa J., Kanayama T., Dakeyama F., Saito K., Imagawa M., Takatori S., Kitagawa Y., Hori S., and Utsumi H. Estrogenic activities of 517 chemicals by yeast two-hybrid assay. J. Health Sci. 46 (2000) 282-298
11. Pittet G., and Ferrer F. UV filters regulatory status in the European Union, Japan and the USA. Öle Fette Wachse-J. 123 (1997) 510-519
12. Rogers S.M., Back D.J., and Orme M.L. Intestinal metabolism of ethinyloestradiol and paracetamol in vitro: studies using Ussing chambers. Br. J. Clin. Pharmacol. 23 (1987) 727-734
13. Schlecht C., Klammer H., Jarry H., and Wuttke W. Effects of estradiol, benzophenone-2 and benzophenone-3 on the expression pattern of the estrogen receptors (ER) alpha and beta, the estrogen receptor-related receptor 1 (ERR1) and the aryl hydrocarbon receptor (AhR) in adult ovariectomized rats. Toxicology 205 (2004) 123-130
14. Schlecht C., Klammer H., Wuttke W., and Jarry H. A dose-response study on the estrogenic activity of benzophenone-2 on various endpoints in the serum, pituitary and uterus of female rats. Arch. Toxicol. 80 (2006) 656-661
15. Schlumpf M., Cotton B., Conscience M., Haller V., Steinmann B., and Lichtensteiger W. In vitro and in vivo estrogenicity of UV screens. Environ. Health Perspect. 109 (2001) 239-244
16. Schmutzler C., Bacinski A., Gotthardt I., Huhne K., Ambrugger P., Klammer H., Schlecht C., Hoang-Vu C., Gruters A., Wuttke W., Jarry H., and Kohrle J. The ultraviolet filter benzophenone 2 interferes with the thyroid hormone axis in rats and is a potent in vitro inhibitor of human recombinant thyroid peroxidase. Endocrinology 148 (2007) 2835-2844
17. Seidlova-Wuttke D., Jarry H., and Wuttke W. Pure estrogenic effect of benzophenone-2 (BP2) but not of bisphenol A (BPA) and dibutylphtalate (DBP) in uterus, vagina and bone. Toxicology 205 (2004) 103-112
18. Shen D.D., Kunze K.L., and Thummel K.E. Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction. Adv. Drug Deliv. Rev. 27 (1997) 99-127
19. Suzuki T., Kitamura S., Khota R., Sugihara K., Fujimoto N., and Ohta S. Estrogenic and antiandrogenic activities of 17 benzophenone derivatives used as UV stabilizers and sunscreens. Toxicol. Appl. Pharmacol. 203 (2005) 9-17
20. Weisbrod C.J., Kunz P.Y., Zenker A.K., and Fent K. Effects of the UV filter benzophenone-2 on reproduction in fish. Toxicol. Appl. Pharmacol. 225 (2007) 255-266
21. Yamasaki K., Takeyoshi M., Yakabe Y., Sawaki M., and Takatsuki M. Comparison of the reporter gene assay for ER-alpha antagonists with the immature rat uterotrophic assay of 10 chemicals. Toxicol. Lett. 142 (2003) 119-131